{"product_id":"owens-minor-five-forces-analysis","title":"Owens \u0026 Minor Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOwens \u0026amp; Minor faces moderate supplier power, steady buyer influence, and evolving threats from substitutes and new entrants as healthcare supply chains shift; competitive rivalry is high due to margin pressure and consolidation in the sector. This brief snapshot only scratches the surface—unlock the full Porter's Five Forces Analysis to explore Owens \u0026amp; Minor’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of Major Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge medical device and pharma manufacturers—like Medtronic, Johnson \u0026amp; Johnson, and Pfizer—hold concentrated market share, letting them set terms; in 2024 top 10 suppliers accounted for roughly 40% of hospital-distributed specialty product spend, boosting their leverage over Owens \u0026amp; Minor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegration into Proprietary Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOwens \u0026amp; Minor cut supplier power by scaling in-house production via Patient Direct and Products \u0026amp; Services; in 2025 their distribution-to-manufacturing mix shifted so private-label sales rose to ~22% of revenue, up from 15% in 2022 (2025 Q3 SEC filing).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Supply Chain Vulnerabilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOwens \u0026amp; Minor's reliance on resin, cotton and non-woven fabrics ties COGS to commodity swings; resin prices rose ~18% year-to-date as of Dec 2025, pushing gross margin pressure. Suppliers gained leverage amid 2024–25 logistics bottlenecks and geopolitical tension, raising lead times by 20–35%. Shortages forced OMI to absorb higher purchase costs or cut inventory; inventory days fell to 52 in Q3 2025, upholding supply continuity at higher expense.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwitching Costs for Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSwitching major suppliers requires complex logistics and risks breaching contract terms with hospitals; Owens \u0026amp; Minor reported 2024 logistics costs of $1.1B, showing sensitivity to supply-chain shifts.\u003c\/p\u003e\n\u003cp\u003eLong-term distribution agreements—often 3–5 years—tie Owens \u0026amp; Minor into supplier ecosystems to secure product availability, limiting quick moves to lower-cost vendors.\u003c\/p\u003e\n\u003cp\u003eThese contracts constrain rapid price-based pivots without endangering service-level agreements and customer retention.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 logistics costs $1.1B\u003c\/li\u003e\n\u003cli\u003eTypical contract length 3–5 years\u003c\/li\u003e\n\u003cli\u003eHigh SLA breach risk if switching\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSuppliers certified to FDA and EU MDR standards are scarce, boosting their bargaining power versus Owens \u0026amp; Minor as of 2025; roughly 30–40% of U.S. medical suppliers hold full FDA QSR compliance, concentrating supply.\u003c\/p\u003e\n\u003cp\u003eOwens \u0026amp; Minor must source only vendors meeting evolving 2025 healthcare regs, shrinking qualified vendors and raising procurement costs and lead-time risk; in 2024 OEM compliance audits rose 18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eRegulatory barriers block lower-cost, unverified suppliers who lack clinical safety guarantees, protecting patient safety but limiting price negotiation and increasing supplier leverage over distributors.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQualified suppliers ~30–40% in U.S.\u003c\/li\u003e\n\u003cli\u003e2024 OEM compliance audits +18% YoY\u003c\/li\u003e\n\u003cli\u003eHigher procurement cost and longer lead times\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSuppliers Dominate: Top-10 40%, Private-Label 22% but Costs Keep Pressure High\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong leverage: top 10 manufacturers ~40% of hospital specialty spend (2024), qualified US suppliers ~30–40%, and long-term 3–5yr contracts limit rapid switching; Owens \u0026amp; Minor raised private-label to ~22% of revenue in 2025 to reduce supplier power, but commodity-driven COGS swings (resin +18% YTD Dec 2025) and logistics costs $1.1B (2024) keep supplier pressure high.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-10 supplier share (2024)\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQualified US suppliers\u003c\/td\u003e\n\u003ctd\u003e30–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate-label revenue (2025)\u003c\/td\u003e\n\u003ctd\u003e~22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResin price change (YTD Dec 2025)\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics costs (2024)\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored exclusively for Owens \u0026amp; Minor, this Porter's Five Forces analysis uncovers key drivers of competition, buyer and supplier power, entry barriers, substitutes, and emerging disruptors shaping its healthcare distribution and supply-chain profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Porter's Five Forces snapshot for Owens \u0026amp; Minor—clarifying supplier, buyer, substitute, entrant, and rivalry pressures to speed strategic decisions and investor presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Group Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGroup Purchasing Organizations (GPOs) pool purchasing by thousands of providers and negotiate steep rebates; about 70–80% of Owens \u0026amp; Minor’s 2024 revenue of $8.1 billion flowed through GPO contracts, giving GPOs strong leverage to push prices down.\u003c\/p\u003e\n\u003cp\u003eBecause GPO-driven sales are high-volume, they compress gross margins—Owens \u0026amp; Minor reported a 2024 gross margin of ~11.5%—so the company must sell services beyond price to protect profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Hospital Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe wave of hospital mergers has produced regional giants controlling roughly 50% of inpatient volumes in several U.S. metro areas by late 2025, increasing buyers’ leverage over suppliers like Owens \u0026amp; Minor.\u003c\/p\u003e\n\u003cp\u003eThose systems now demand bespoke logistics, just-in-time inventory, and double-digit price concessions—discounts often 5–15% larger than with independent hospitals.\u003c\/p\u003e\n\u003cp\u003eGiven that top 10 health systems can represent 20–30% of a distributor’s revenue, losing one large client poses major financial and operational risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow Switching Costs for Standardized Goods\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFor commodity medical supplies, hospitals can switch easily between distributors like Cardinal Health or Medline because products are standardized, so price and delivery reliability dominate purchasing decisions.\u003c\/p\u003e\n\u003cp\u003eIn 2024, US hospital supply spend exceeded $70bn and procurement teams report price\/delivery as top 2 criteria, forcing Owens \u0026amp; Minor to match rivals on pricing and next-day fill rates to avoid churn.\u003c\/p\u003e\n\u003cp\u003eThat pressure drives Owens \u0026amp; Minor to invest in service levels and tech—inventory visibility and automated replenishment—to protect gross margins and retain large buyers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDemand for Data-Driven Transparency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eModern health systems now require inventory analytics and cost-transparency as standard: 2024 surveys show 72% of hospitals prioritize real-time tracking and predictive replenishment to cut supply waste by up to 15% and lower inventory carrying costs by 8–12%.\u003c\/p\u003e\n\u003cp\u003eOwens \u0026amp; Minor risks losing contracts if it lacks these tools; buyers use digital capability as leverage to negotiate price cuts or switch to distributors offering integrated SaaS platforms and EMR connectivity.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e72% of hospitals demand real-time tracking\u003c\/li\u003e\n\u003cli\u003e15% potential waste reduction via analytics\u003c\/li\u003e\n\u003cli\u003e8–12% lower carrying costs expected\u003c\/li\u003e\n\u003cli\u003eDigital capability = switching leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Provider Models\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpsome manufacturers now ship high-value devices directly to hospitals threatening bypass distributors if fees exceed perceived value in of u.s. hospital capital purchases used direct channels up from\u003e\n\u003cpowens minor must prove its worth through superior last-mile delivery vendor-managed inventory and data-driven optimization that reduces hospital stockouts carrying costs by measurable margins.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eDirect channel growth: 12–18% of hospital capital buys (2024)\u003c\/li\u003e\n\u003cli\u003eDistributor fee pressure: hospitals seek ≥10–15% cost savings\u003c\/li\u003e\n\u003cli\u003eOwens \u0026amp; Minor moat: last-mile SLAs, VMI, data analytics\u003c\/li\u003e\n\u003cli\u003eRisk: manufacturers cutting middleman if value \u0026lt; fee\u003c\/li\u003e\n\n\u003c\/powens\u003e\u003c\/psome\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOwens \u0026amp; Minor faces GPO-driven margin squeeze; digital \u0026amp; VMI key to retention\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers (GPOs, large health systems) hold strong leverage—70–80% of Owens \u0026amp; Minor’s 2024 $8.1B revenue flowed via GPOs—forcing price concessions (5–15%) and margin pressure (2024 gross margin ~11.5%); top 10 systems can be 20–30% of revenue so churn is material. Hospitals favor price, next-day fill, and digital tools (72% demand real-time tracking), driving Owens \u0026amp; Minor to invest in VMI, analytics, and last-mile SLAs to retain contracts.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue via GPOs\u003c\/td\u003e\n\u003ctd\u003e70–80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 revenue\u003c\/td\u003e\n\u003ctd\u003e$8.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 gross margin\u003c\/td\u003e\n\u003ctd\u003e~11.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals demanding real-time tracking (2024)\u003c\/td\u003e\n\u003ctd\u003e72%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect channel share (capital buys, 2024)\u003c\/td\u003e\n\u003ctd\u003e12–18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eOwens \u0026amp; Minor Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Owens \u0026amp; Minor Porter’s Five Forces analysis you'll receive after purchase—fully formatted, professionally written, and ready for immediate download with no placeholders or samples.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747450925433,"sku":"owens-minor-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/owens-minor-five-forces-analysis.png?v=1772198631","url":"https:\/\/matrixbcg.com\/products\/owens-minor-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}